Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 4, keine Gesamtzahl für „Reyataz“
Suchtreffer
Begriffe & Kennungen
Reyataz · 4.5 · 56 Medicinal products by Interaction Recommendations therapeutic area concerning co-administration Fluticasone
Eintrag öffnenReyataz · 4.5 · 57 Medicinal products by Interaction Recommendations therapeutic area concerning co-administration KINASE INHI
Eintrag öffnenReyataz · 4.5 · 58 Medicinal products by Interaction Recommendations therapeutic area concerning co-administration Ethinyloest
Eintrag öffnenReyataz · 4.5 · 59 Medicinal products by Interaction Recommendations therapeutic area concerning co-administration INHALED BET
Eintrag öffnenReyataz · 4.5 · 60 Medicinal products by Interaction Recommendations therapeutic area concerning co-administration SEDATIVES B
Eintrag öffnenReyataz · 4.5 · 8 Co-administration of REYATAZ with grazoprevir-containing products, including elbasvir/grazoprevir fixed-dose
Eintrag öffnenReyataz · 4.5 · 9 Medicinal products by Interaction Recommendations concerning co- therapeutic area administration Sofosbuvir
Eintrag öffnenReyataz · 4.5 · A dose reduction of clarithromycin may result in subtherapeutic concentrations of 14-OH clarithromycin.
Eintrag öffnenReyataz · 4.5 · A dose reduction of clarithromycin may result in subtherapeutic concentrations of 14-OH clarithromycin.
Eintrag öffnenReyataz · 4.5 · Atazanavir AUC: ↑28% (↑16% ↑43%) Atazanavir Cmax: ↔6% (↓7% ↑20%) Atazanavir Cmin: ↑91% (↑66% ↑121%)
Eintrag öffnenReyataz · 4.5 · Atazanavir AUC: ↑28% (↑16% ↑43%) Atazanavir Cmax: ↔6% (↓7% ↑20%) Atazanavir Cmin: ↑91% (↑66% ↑121%)
Eintrag öffnenReyataz · 4.5 · Atazanavir concentrations were greatly decreased when co-administered with didanosine (buffered tablets) and s
Eintrag öffnenReyataz · 4.5 · Atazanavir concentrations were greatly decreased when co-administered with didanosine (buffered tablets) and s
Eintrag öffnenReyataz · 4.5 · Atazanavir is metabolised in the liver through CYP3A4. It inhibits CYP3A4. Therefore, REYATAZ is contraindicat
Eintrag öffnenReyataz · 4.5 · Atazanavir is metabolised in the liver through CYP3A4. It inhibits CYP3A4. Therefore, REYATAZ with ritonavir i
Eintrag öffnenReyataz · 4.5 · Close monitoring of patient's virologic response should be exercised. Lamotrigine Co-administration of lamotri
Eintrag öffnenReyataz · 4.5 · Close monitoring of patient's virologic response should be exercised. Lamotrigine Co-administration of lamotri
Eintrag öffnenReyataz · 4.5 · Close monitoring of the patient's virologic response should be exercised.
Eintrag öffnenReyataz · 4.5 · Close monitoring of the patient's virologic response should be exercised. Phenytoin, phenobarbital Ritonavir m
Eintrag öffnenReyataz · 4.5 · Effect on atazanavir and ritonavir exposure has not been studied. Expected: ↔ Atazanavir ↔ Ritonavir
Eintrag öffnen